U.S. PPG Biosensors Market Summary

The U.S. PPG biosensors market size was valued at USD 152.1 million in 2023 and is projected to grow at a CAGR of 12.7% from 2024 to 2030. The demand for photoplethysmography (PPG) technology has risen significantly as it serves as an effective and economical alternative for heart rate monitoring. Its adoption is fueled by the increasing prevalence of cardiovascular disorders (CVDs), rising awareness of preventive healthcare, and the widespread use of wearable devices and smartwatches. PPG technology is versatile, making it suitable for integration into diverse product formats, including watches, rings, patches, earbuds, and other connected devices.

The growing prevalence of CVDs is expected to remain a primary driver for market expansion. As per data from the Centers for Disease Control and Prevention (CDC), approximately 695,000 U.S. citizens lose their lives annually due to cardiovascular diseases. PPG-based technologies, in combination with digital health innovations, have proven instrumental in improving early detection of cardiac issues, enabling timely treatment interventions, and reducing CVD-related mortality. Being a non-invasive and cost-effective method compared to electrocardiography (ECG) sensors, PPG can be conveniently deployed at several body sites, such as the fingers, toes, ears, wrists, chest, and head, which enhances its usability and accessibility in medical and consumer health applications.

Key Market Trends & Insights

• In terms of product segmentation, the smart watch segment accounted for the largest market share of over 40% in 2023 and is projected to register the fastest growth during the forecast period. The product category of PPG biosensors is broadly classified into pulse oximeters, smart watches, smart wristbands, and other wearable solutions, including patches and rings. Among these, smart wearables with PPG-based health tracking functions have rapidly penetrated the consumer market due to their multifunctional utility and integration with mobile health applications.
• On the basis of applications, the heart rate monitoring segment dominated the market in 2023 and is expected to witness substantial growth over the coming years. Smart wearable devices, which rely on PPG sensors, are increasingly being used for continuous heart rate monitoring by fitness enthusiasts, healthcare professionals, and patients with cardiac conditions.
• Other application segments include blood-oxygen saturation measurement, blood pressure monitoring, respiration rate analysis, and sleep monitoring. The blood-oxygen saturation segment is anticipated to grow at the fastest CAGR from 2024 to 2030. This application uses dual-wavelength PPG technology for accurate and non-invasive assessment of arterial oxygen saturation (SpO2), making it highly relevant in both clinical and home healthcare settings.

Order a free sample PDF of the U.S. PPG Biosensors Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 152.1 million
• 2030 Projected Market Size: USD 340.1 million
• CAGR (2024 - 2030): 12.7%

Key Companies & Market Share Insights

The competitive landscape of the U.S. PPG biosensors market includes several key players who are focusing on innovation and advanced sensor integration. Masimo Corporation is a leading manufacturer with a strong portfolio of PPG-based monitoring products such as the Rad-57 Pulse Oximeter, Rad-97 Pulse CO-Oximeter, Radius-7 Pulse CO-Oximeter, Rad-5 Adult Finger Pulse Oximeter, Rad-8 Vital Signs Monitor, and Rad-87 Neonatal Pulse CO-Oximeter. Valencell, Inc. stands out as a pioneer in biometric sensor innovation, particularly in PPG biosensors, offering proprietary audio-based biometric sensor technology licensed to multiple consumer electronics, sports, and healthcare brands. In addition, Nonin Medical, Inc., Omron Healthcare, BioTech Instruments, Inc., and CureX, Inc. are notable market participants contributing to competitive dynamics through diversified offerings and technological advancements.

Key Players

• Masimo Corporation
• Valencell. Inc.
• Maxim Integrated
• Nonin Medical, Inc.
• Rockley Photonics
• Omron Healthcare
• BioTech Instruments, Inc.
• CureX, Inc.
• Preventice Solutions

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. PPG biosensors market is positioned for strong growth, supported by rising cardiovascular health concerns, increasing adoption of wearable technologies, and advances in non-invasive monitoring methods. As consumer demand for continuous health tracking rises, companies are investing in innovation to deliver compact, accurate, and user-friendly biosensor solutions. With smart watches and wearable devices dominating product adoption, the market is expected to see accelerated growth across healthcare and consumer wellness applications. The shift toward preventive healthcare, remote patient monitoring, and personalized medical interventions will continue to create opportunities, establishing PPG biosensors as a critical component of modern healthcare solutions.